American Research & Management Co. Gsk PLC Transaction History

American Research & Management Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$38.79 - $43.16 $969 - $1,079	-25 Reduced 3.85%	624 $24,000
Q1 2021 Apr 06, 2021	BUY	$34.27 - $40.01 $13,673 - $15,963	399 Added 159.6%	649 $23,000
Q1 2020 Apr 28, 2020	SELL	$32.47 - $48.83 $3,247 - $4,883	-100 Reduced 28.57%	250 $9,000
Q2 2019 Jul 18, 2019	SELL	$39.4 - $42.7 $39,400 - $42,700	-1,000 Reduced 74.07%	350 $14,000
Q1 2019 Apr 16, 2019	BUY	$38.57 - $42.69 $38,570 - $42,690	1,000 Added 285.71%	1,350 $56,000
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $7,559 - $8,538	-200 Reduced 36.36%	350 $13,000
Q3 2017 Oct 17, 2017	BUY	$39.44 - $41.55 $21,692 - $22,852	550	550 $22,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

Stay updated on American Research & Management Co. with notifications on news.